Australia's pharmacy funding model fuels monopoly fees and stifles competition, exposing systemic market and policy failures
Original framing: “Unfair fees and low competition: why the pharmacy sector needs a shake up” — The Conversation - Global
Economic modelling demonstrates that increased competition can reduce dispensing fees by up to 15 % without compromising safety, while health outcomes improve when pharmacists are embedded in primary‑care teams. Empirical data from OECD health systems support these findings.
The Australian pharmacy sector’s fee inequities stem from a historically entrenched monopoly that benefits from opaque funding negotiations and regulatory capture, marginalising Indigenous and rural voices.
Cross‑cultural evidence shows that opening the market to diverse providers and integrating traditional health structures can lower costs and improve access. Transparent governance, community‑based health hubs, and digital decentralisation together form a systemic pathway that aligns economic efficiency with health equity, drawing on scientific modelling, historical lessons, and the disruptive insight of the trickster archetype to reconfigure the power balance in pharmaceutical care.